Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Core Scientific (CORZ) Debt to Equity (2021 - 2025)

Core Scientific's Debt to Equity history spans 5 years, with the latest figure at -$0.94 for Q3 2025.

  • For Q3 2025, Debt to Equity fell 63.53% year-over-year to -$0.94; the TTM value through Sep 2025 reached -$0.94, down 63.53%, while the annual FY2024 figure was -$1.31, 14.27% down from the prior year.
  • Debt to Equity for Q3 2025 was -$0.94 at Core Scientific, down from -$0.89 in the prior quarter.
  • Across five years, Debt to Equity topped out at $2.06 in Q2 2022 and bottomed at -$3.47 in Q1 2025.
  • The 5-year median for Debt to Equity is -$0.45 (2024), against an average of -$0.51.
  • The largest annual shift saw Debt to Equity skyrocketed 2168.09% in 2022 before it tumbled 388830.33% in 2024.
  • A 5-year view of Debt to Equity shows it stood at $0.49 in 2021, then tumbled by 85.11% to $0.07 in 2022, then plummeted by 1682.89% to -$1.15 in 2023, then dropped by 14.27% to -$1.31 in 2024, then rose by 28.3% to -$0.94 in 2025.
  • Per Business Quant, the three most recent readings for CORZ's Debt to Equity are -$0.94 (Q3 2025), -$0.89 (Q2 2025), and -$3.47 (Q1 2025).